4 completed, 1 unknown. 2 Not applicable, 2 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
| Phase 4 | 1 | Unknown 1 |
Follow influvac: new trials by email Literature Review of influvac trials Research Report on influvac
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Response to Influenza Vaccination in Lymphoma Patients Treated With Rituximab influenza vaccination with influenza vaccine - Non-Hodgkin Lymphoma (NHL) | Not applicable | Completed | St. Antonius Hospital | 98 | 2012-10-01 | 2014-01-31 |
| Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 2012/2013 Season Trivalent influenza subunit vaccine Influvac - Prophylaxis of Influenza | Phase 3 | Completed | Abbott Biologicals | 120 | 2012-07-01 | 2012-08-06 |
| Response to Influenza Virus Vaccination in Patients Immunocompromised Due to Chemotherapy influenza virus vaccine (influvac or vaxigrip) - Mamma Carcinoma, Heart Failure | Not applicable | Completed | St. Antonius Hospital | 50 | 2009-10-01 | 2009-12-18 |
| Comparison of the Cellular and the Humoral Immunogenicity, Safety of Different Trivalent Influenza Vaccines influenza vaccine - Healthy Volunteers | Phase 4 | Unknown | National Centre for Epidemiology, Hungary | 85 | 2008-11-01 | 2010-05-07 |
| Non-Inferiority Study Comparing the Subunit Vaccines Influvac and Agrippal in China Influvac; subunit influenza vaccine - Healthy | Phase 3 | Completed | Solvay Pharmaceuticals | 900 | 2006-03-01 | 2006-11-01 |
Influenza, Human (5) · Heart Failure (1) · Lymphoma, Non-Hodgkin (1)
St. Antonius Hospital (2) · Abbott Biologicals (1) · National Centre for Epidemiology, Hungary (1) · Solvay Pharmaceuticals (1)
Netherlands (2) · China (1) · Germany (1) · Hungary (1)
Douwe Biesma, Prof, Dr (1) · Minke AE Rab, Drs. (1) · Okke de Weerdt, Drs (1) · Serge van de Witte, PhD (1)
2008 (1)